ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

EDIT Editas Medicine Inc

6,02
0,00 (0,00%)
Pré-mercado
Última atualização: 05:00:08
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Editas Medicine Inc EDIT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 6,02 05:00:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,02
mais cotações »

Notícias Recentes

Data Hora Fonte Título
10/05/202407:00GLOBEEditas Medicine Preclinical Data Highlights Advancement of..
08/05/202409:29IHMARKETNEWSU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet..
08/05/202408:00GLOBEEditas Medicine Announces First Quarter 2024 Results and..
02/05/202408:00GLOBEEditas Medicine Announces First Quarter 2024 Results..
01/05/202409:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
22/04/202417:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
28/02/202409:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
21/02/202409:00GLOBEEditas Medicine Announces Fourth Quarter and Full Year 2023..
31/01/202411:00GLOBEEditas Medicine to Participate in Upcoming Investor..
08/01/202410:15GLOBEEditas Medicine Highlights 2024 Anticipated Milestones and..
03/01/202409:00GLOBEEditas Medicine to Present at the 42nd Annual J.P. Morgan..
13/12/202314:48DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202311:49DJNEditas Medicine Strikes License Deal With Vertex..
13/12/202311:00GLOBEEditas Medicine and Vertex Pharmaceuticals Enter into..
11/12/202314:00GLOBEEditas Medicine Announces New EDIT-301 Safety and Efficacy..
03/11/202308:00GLOBEEditas Medicine Announces Third Quarter 2023 Results and..
02/11/202310:12GLOBEEditas Medicine to Present Clinical Data from the RUBY and..
27/10/202308:00GLOBEEditas Medicine Announces Third Quarter 2023 Results..
16/10/202309:00GLOBEEditas Medicine Granted FDA Regenerative Medicine Advanced..
25/09/202317:30GLOBEEditas Medicine Reports Inducement Grants to New Chief..
25/09/202310:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
30/08/202310:00GLOBEEditas Medicine Announces Upcoming Investor Events
28/08/202308:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
02/08/202308:00GLOBEEditas Medicine Announces Second Quarter 2023 Results and..
27/07/202310:00GLOBEEditas Medicine and Azzur Group Expand Partnership to..
26/07/202308:00GLOBEEditas Medicine Announces Second Quarter 2023 Results..
25/07/202309:00GLOBEEditas Medicine Reports Inducement Grant to New Chief..
24/07/202308:00GLOBEEditas Medicine Strengthens Executive Leadership Team with..
14/06/202323:06GLOBEEditas Medicine Announces Pricing of Offering of Common..
14/06/202317:05GLOBEEditas Medicine Announces Offering of Common Stock
09/06/202304:00GLOBEEditas Medicine Announces Positive Initial EDIT-301 Safety..
06/06/202309:00GLOBEEditas Medicine to Host Virtual Event to Discuss EDIT-301..